Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Banting Postdoctoral Fellowship Program

Direct Payment

$140,000.00

Mutation-specific directed evolution of CRISPR-Cas prime editors in human cells

FY 2022-23

Summary
The development of CRISPR-Cas genome editing tools has transformed the life sciences and medicine. Arguably, the most successful advances have come in the form of increased specificity and precision of the genome modifications achievable using CRISPR-Cas systems. Most recently, the development of prime editing has enabled the introduction of virtually any modification-of-interest in a targeted fashion. The widespread therapeutic application of prime editors, however, is undermined by inconsistent and low editing efficiencies. Here, I propose the establishment of a directed evolution platform that can be deployed for the optimization of prime editing enzymes for mutation-specific correction. To demonstrate the feasibility of this approach, a prime editor enzyme will be evolved for high-efficiency correction of a mutation underlying cystic fibrosis that is currently therapeutically unaddressed. Successful completion of this project will establish a methodology for the rapid development of bespoke prime editing enzymes that are optimized during evolution for the correction of a specific genetic variant. Furthermore, the data generated will support the further development of a potentially curative one-time treatment for cystic fibrosis patients.
Program
Banting Postdoctoral Fellowship Program
Location
Massachusetts, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
471421
Name
Erwood Steven
Region
Massachusetts
Country
United States of America
Orgtype
Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Banting Postdoctoral Fellowships Program
Projecttitle
Mutation-specific directed evolution of CRISPR-Cas prime editors in human cells
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$140,000
Cihrequipment2
$0
Programname2
Banting Postdoctoral Fellowship Program
Keyworddelim
Cystic Fibrosis; Directed Evolution; Gene Editing; Prime Editing
Abstract
The development of CRISPR-Cas genome editing tools has transformed the life sciences and medicine. Arguably, the most successful advances have come in the form of increased specificity and precision of the genome modifications achievable using CRISPR-Cas systems. Most recently, the development of prime editing has enabled the introduction of virtually any modification-of-interest in a targeted fashion. The widespread therapeutic application of prime editors, however, is undermined by inconsistent and low editing efficiencies. Here, I propose the establishment of a directed evolution platform that can be deployed for the optimization of prime editing enzymes for mutation-specific correction. To demonstrate the feasibility of this approach, a prime editor enzyme will be evolved for high-efficiency correction of a mutation underlying cystic fibrosis that is currently therapeutically unaddressed. Successful completion of this project will establish a methodology for the rapid development of bespoke prime editing enzymes that are optimized during evolution for the correction of a specific genetic variant. Furthermore, the data generated will support the further development of a potentially curative one-time treatment for cystic fibrosis patients.
Competitiondate
202209
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Erwood, Steven
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $140,000~ $0~
Direct Payment - $140,000 Grant (2022-23) | Canada Spends